Table 2.
N | YWHAZ immunoreactivity | * P-value | |||
---|---|---|---|---|---|
| |||||
Low expression | High expression | ||||
Total | Absent | 62 | 22 (52%) | 40 (80%) | |
Present | 30 | 20 (48%) | 10 (20%) | 0.0049 | |
Hematogenous | |||||
Absent | 85 | 38 (90%) | 47 (94%) | ||
Present | 7 | 4 (10%) | 3 (6%) | 0.5254 | |
Distant orlocal lymph node | |||||
Absent | 84 | 35 (83%) | 49 (98%) | ||
Present | 8 | 7 (17%) | 1 (2%) | 0.0129 | |
Peritoneal | |||||
Absent | 83 | 35 (83%) | 48 (96%) | ||
Present | 9 | 7 (17%) | 2 (4%) | 0.0416 | |
Local | |||||
Absent | 91 | 41 (98%) | 50 (100%) | ||
Present | 1 | 1 (2%) | 0 (0%) | 0.2726 | |
Other | |||||
Absent | 86 | 41 (98%) | 46 (92%) | ||
Present | 5 | 1 (2%) | 4 (8%) | 0.2363 |
Note: Statistically significant values are in boldface type;
P-values are from χ2 or Fisher’s exact test and were statistically significant at <0.05.